Private Capital Advisors’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Private Capital Advisors’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235K	Buy	+419	New	+$235K	0.02%	68
2022 Q4	–	Sell	-3,013	Closed	-$349K	–	90
2022 Q3	$349K	Buy	+3,013	New	+$1.03K	0.06%	64
2015 Q3	–	Sell	-2,125	Closed	-$346K	–	128
2015 Q2	$346K	Buy	+2,125	New	+$360K	0.11%	118

Private Capital Advisors's SIOX Position: Q2 2026 in Review

Private Capital Advisors opened a new position in Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2026: 419 shares worth $235K. The stake represents 0.02% of the portfolio and ranks #68 among its holdings. This is a return to the name: Private Capital Advisors previously reported a position in SIOX as recently as Q3 2022.

Private Capital Advisors first reported a position in SIOX in Q2 2015 and has held it in 3 quarters since. The position peaked at $349K in Q3 2022. 1 fund tracked by Wall St. Rank holds SIOX as of Q2 2026.

Private Capital Advisors held 419 shares of Sio Gene Therapies Inc. Common Stock worth $235K as of Q2 2026.
Sio Gene Therapies Inc. Common Stock was a new Private Capital Advisors position in Q2 2026.
Sio Gene Therapies Inc. Common Stock made up 0.02% of Private Capital Advisors's portfolio in Q2 2026, its #68 holding.
Private Capital Advisors first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and has held it in 3 quarters since.
Private Capital Advisors's Sio Gene Therapies Inc. Common Stock position peaked at $349K in Q3 2022.
1 fund tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2026.

Based on Private Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.